Available Until 5/7/2024

ACCP/ASHP BCOP Webinar Series: Precision Medicine Strategies in Oncology Treatment and Supportive Care (Cert # L239235)

ACPE Numbers: 0217-9999-23-030-H01-P
Pre-Sale Date: 04/14/2023
Content Release Date: 05/10/2023
Expiration Dates: 05/07/2024
CE Credits: 1.5 (ACPE and BPS)
Activity Fee: $99 (ASHP member); $159 (non-member) 

Activity Overview

This webinar recording series is part of the professional development program for the recertification of the BCOP pharmacist. 

This course is intended for BCOPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice. 

This online activity is approved for 1.5 hours of continuing pharmacy education credit and/or recertification credit. 

This webinar provides a review of germline and somatic variation impacting efficacy and toxicity profiles for oncology treatment and supportive care as well as the selection of targeted therapies.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.



The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.

The target audience for this webinar recording is the pharmacist interested in learning more about updated information regarding oncologic management and/or treatment, and for Board-certified Oncology Pharmacists (BCOPs) looking to earn recertification credit.

Board certified pharmacists are eligible to receive up to 1.5 hours of recertification credit for completing this webinar. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment. 

This webinar is not intended for those preparing to take the BPS Oncology Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/onc-review. 

These activities are part of the ACCP and ASHP professional development program for BCOP recertification approved by the BPS. 

For full program information, please visit: http://elearning.ashp.org/catalog/onc-recert

Learning Activity

ACPE Number

Contact Hours (ACPE and BPS)

Assessment Pass Point

ACCP/ASHP BCOP On-Demand Series: Precision Medicine Strategies in Oncology Treatment and Supportive Care 




After participating in this CPE activity, learners should be able to:

  • Examine genomic sequencing methods utilized in patients with cancer.
  • Differentiate between evidence-based resources in evaluating both germline and somatic variation in patients with cancer.
  • Design a patient-specific oncology or supportive care regimen utilizing pharmacogenomic test results.
  • Evaluate genomic testing results to determine appropriate targeted therapies for patients with cancer.
  • Analyze results of recent trials evaluating precision medicine-based oncologic therapies.

Courtney S. Watts Alexander, PharmD, BCPS, BCOP
Assistant Professor, Clinical Pharmacogenomics
Auburn University, Harrison College of Pharmacy
Auburn, Alabama

David D. Quach, Pharm.D., MPH, BCPS, BCOP
Kelsey C. Zielke, Pharm.D., BCPS, BCOP

Kimberly Creswell, PharmD, BCOP
Kristin Gililland, PharmD, BCPS, BCOP
Elisabeth Hebert, BPharm, MSc, BCOP
Elle Kim, RPh, BCPS, BCOP
Jonathan Malara, PharmD, BCOP
Lilian May, PharmD, BCOP, BCPS
Megan Mullalley, PharmD, BCOP, BCPS
Danielle Otto, PharmD, BCOP
Carol Peek, PharmD, BCOP
Mohammad Rattu, PharmD, BCOP, BCPS, BCGP
Hope Schenk, PharmD, BCOP
Carol Stadler, PharmD, BCOP
Malgorzata Tyszka, BSc, Pharm, BCOP
Hope Welch, PharmD, BCOP
Sarabeth Wojnowicz, PharmD, BCOP
Carolnn Yong, PharmD, BCOP, BCPS

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ACCP and ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speaker’s bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ACCP and ASHP education activities are qualified and selected by ACCP and ASHP and required to disclose any relevant financial relationships with commercial interests. ACCP and ASHP identify and resolve conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

All other planners, presenters, reviewers, ASHP and ACCP, and others with an opportunity to control content report no financial relationships relevant to this activity.

This activity consists of audio and slides, an attestation statement, and an activity evaluation. Learners must review all content and complete the attestation statement and evaluation to receive continuing pharmacy education credit for the activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

ACCP collaborates with ASHP on oncology pharmacy activities.